TargetVascular endothelial growth factor receptor 2(Homo sapiens (human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 0.380nMAssay Description:A competition binding assay, was used to measure the ability of a compound to compete for binding of an immobilized adenosine triphosphate (ATP) site...More data for this Ligand-Target Pair